Ralf Zahn

Showing 1-14 of 14 articles

Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)

Nef H, Wiebe J, Kastner J, Mehilli J, Münzel T, Naber C, Neumann T, Richardt G, Schmermund A, Wöhrle J, Zahn R, Riemer T, Achenbach S, Hamm C

December 20, 2017 | 10.4244/EIJ-D-17-00330

Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R

Mehilli J, Achenbach S, Wöhrle J, Baquet M, Riemer T, Münzel T, Nef H, Naber C, Richardt G, Zahn R, Gori T, Neumann T, Kastner J, Schmermund A, Hamm C, Wöhrle J, Richardt G

December 20, 2017 | 10.4244/EIJ-D-17-00291

Interventions for valvular disease

How should I treat recurrent severe paravalvular leakage after successful interventional closure of a symptomatic paravalvular leak with four plug devices following complicated bioprosthetic aortic valve replacement? The importance of closely monitoring patients after interventional procedures

Werner N, Kilkowski C, Fraiture B, Zeymer U, Zahn R, Gafoor S, Butera G

September 20, 2017 | 10.4244/EIJ-D-15-00001

Interventions for valvular disease

Left ventricular function determines the survival benefit for women over men after transcatheter aortic valve implantation (TAVI)

Bauer T, Möllmann H, Beckmann A, Ensminger S, Frerker C, Holzhey D, Berkowitsch A, Zahn R, Mohr F, Hamm C, Walther T

July 20, 2017 | 10.4244/EIJ-D-16-00622

Interventions for stroke

The shrinking carotid stent

Keranov S, Zahn R, Zeymer U

June 20, 2016 | 10.4244/EIJV12I3A67

Immediate multivessel percutaneous coronary intervention versus culprit lesion intervention in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry

Zeymer U, Hochadel M, Thiele H, Andresen D, Schühlen H, Brachmann J, Elsasser A, Gitt A, Zahn R

July 20, 2015 | 10.4244/EIJY14M08_04

TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)

Lauten A, Figulla HR, Möllmann H, Holzhey D, Kotting J, Beckmann A, Veit C, Cremer J, Kuck K, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Meinertz T, Neumann T, Welz A, Mohr F, Hamm C

November 20, 2014 | 10.4244/EIJV10I7A145

Transcatheter aortic valve implantation (TAVI) by centres with and without an on-site cardiac surgery programme: preliminary experience from the German TAVI registry

Eggebrecht H, Mehta R, Haude M, Sack S, Mudra H, Hein R, Brachmann J, Gerckens U, Kuck K, Zahn R, Sechtem U, Richardt G, Schneider S, Senges J

September 28, 2014 | 10.4244/EIJV10I5A105

A plea for caution: transcatheter aortic valve implantation using the Medtronic CoreValve™ prosthesis without balloon predilatation

Zahn R, Bauer T, Sack F-U, Lehman A, Cornelius B, Schiele R

September 27, 2013 | 10.4244/EIJV9I5A105

Outcome of patients after emergency conversion from transcatheter aortic valve implantation to surgery

Hein R, Abdel-Wahab M, Sievert H, Kuck K, Voehringer M, Hambrecht R, Sack S, Hauptmann K-E, Senges J, Zahn R, Mudra H

August 23, 2013 | 10.4244/EIJV9I4A73

Age-related differences in diagnosis, treatment and outcome of acute coronary syndromes: results from the German ALKK registry

Rittger H, Hochadel M, Behrens S, Hauptmann K-E, Zahn R, Mudra H, Brachmann J, Senges J, Zeymer U

February 21, 2012 | 10.4244/EIJV7I10A191

Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI

Zeymer U, Bauer T, Hamm C, Zahn R, Weidinger F, Seabra-Gomes R, Hochadel M, Marco J, Gitt A

August 30, 2011 | 10.4244/EIJV7I4A72

Contemporary success and complication rates of percutaneous coronary intervention for chronic total coronary occlusions: results from the ALKK quality control registry of 2006

Werner G, Hochadel M, Zeymer U, Kerber S, Schumacher B, Grube E, Hauptmann K-E, Brueck M, Zahn R, Senges J

August 15, 2010

Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention

Zeymer U, Gitt A, Zahn R, Jünger C, Bauer T, Heer T, Koeth O, Senges J

January 20, 2009

1

Latest news

Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…

Tetralogy of Fallot with acquired double right ventricular outflow tract

September 18, 2020

Ahead of print: Leaflex Study

September 23, 2020

Integrating physiology in OCT

September 23, 2020

VOYAGER PAD, PARTNER 2A, ISCHEMIA and much more

(The Trials book is supported by Biotronik)

August 28, 2020

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Steady-state hyperaemia

September 18, 2020

This Week's JAA's: Biograde Study, Advances in valvular heart interventions...

September 22, 2020

Valvular disease